Opportunity for Study Start Up Associate at ICON
ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support Clinical Development – from compound selection to Phase I - IV clinical studies
ICON enjoys a strong reputation for quality and is focused on staff development. We make it our mission to attract the most diverse and creative minds into the business and we continually strive to provide opportunities for our people to excel, grow and build a great career. We understand that our greatest asset is the skills and talents of our people and they are truly what set us apart.
Post : Study Start Up Associate I

Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter had 2012 sales of $14.2 billion and has approximately 50,800 employees.
Siddha Central Research Institute (SCRI) is the pioneer institute for research established in the year 1971 to spin in all spheres of Siddha Research such as Clinical Research, Drug Development and Literary research. It is governed by Institutional Human Ethics Commitee, Institutional Animal Ethics Commitee and having adequate infrastructure and various departments like Clinical research, Pharmacognosy, Phytochemistry, Pharmacology, Literary research and Pharmacy. This institute is located in the campus of Arignar Anna Government Hospital of Indian Systems of medicine at Arumbakkam, Chennai. This institute is instrumental in getting the Patent for Psoriasis and is a referral centre for Psoraisis. Recently this institute has published a patent for Poly herbal drug D5 Chooranam useful for newly detected Type 2 Diabetes.


